VTRS — Viatris Inc.
Healthcare · ETF XLV · as of 2026-07-20
Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · RS vs SPY ⓘ our data
Viatris Inc.
NMS
Healthcare · Drug Manufacturers - Specialty & Generic
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and...
Fundamentals & valuation - reference, not entry inputs
P/E (TTM)
-
Fwd P/E
6.4
PEG
0.1
Price/Book
1.2
Profit margin
-24.6%
ROE
-21.1%
Debt/Equity
99.9
Rev growth
+5.0%
Analyst target
$16 (-7%)
Analyst rating
BUY
Institutional %
86.4%
Insider %
0.4%
Float %
98.0%
Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.
MarketSmith metrics - our compute
RS Rating
88.3
ADR%
2.8
RMV (tight)
94.0
Ext (ATR>20EMA)
0.9
Rel Vol
73.0%
U/D Ratio
1.1
EPS YoY
-11.0%
LoD dist
5.0
Off 52w High
3.8%
Above 52w Low
97.0%
1W / 1M
+3.7 / +8.0
Avg $Vol 50d
176.5M
Mkt Cap (B)
19.8
Trend 8/8
YES
Leads Group
YES
Sector XLV
-1.3% 1W
Base len (VCP)
11wk (7/20)
not available: vol_buzz(formula TODO from swing-data.txt)
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D Ratio
- - up-day vs down-day volume, 50 days. 1.1+ = net accumulation.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP/momentum pivots.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Company data - context read, not entry inputs
Industry rank
111 / 131
Industry
Drug Manufacturers - Specialty & Generic
Float
1.14B
Float turnover 20d
0.8%
Avg $Vol 20d / 50d
156.4M / 176.5M
Days to cover
4.0
Short % float
3.0%
Institutional %
86.4%
Weinstein stage
2
Float, short interest and institutional % come from Yahoo company stats, refreshed weekly for ~3,000 larger names - a blank means Yahoo does not publish the figure for this stock, not that it is zero. Dollar volume and float turnover are computed from our own price bars; industry rank from our rotation data; stage from the weekly chart.
Quarterly EPS - earnings acceleration
| Quarter | EPS ($) | %Chg YoY | Sales ($M) | %Chg |
|---|---|---|---|---|
| Feb-24 | 0.62 | -7% | 3,837.3 | -2% |
| May-24 | 0.67 | -13% | 3,653.5 | -2% |
| Aug-24 | 0.69 | -8% | 3,796.6 | -3% |
| Nov-24 | 0.75 | -5% | 3,751.2 | -5% |
| Feb-25 | 0.54 | -13% | 3,481.6 | -9% |
| May-25 | 0.50 | -25% | 3,254.3 | -11% |
| Aug-25 | 0.62 | -10% | 3,569.0 | -6% |
| Nov-25 | 0.67 | -11% | 3,759.9 | +0% |
EPS = Yahoo adjusted, matches MarketSmith/Deepvue - NOT TradingView's GAAP · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).
Price & today
$16.99
ATR(14) 0.48 (2.85%)
| Stock today | -1.74% |
| Sector ETF today | -1.14% |
| Residual (stock-specific) | -0.59% |
Sector correlation
| 20-day correlation with XLV | 0.76 |
| 60-day correlation with XLV | 0.44 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $16.77 |
| 20 EMA | $16.55 |
| 50 EMA | $16.11 |
| EMA stack | BULLISH |
| RSI(14) | 58.5 |
| 52-week high distance | +3.16% |
| 52-week low distance | +107.45% |
Signals
| Market F&G | 57.3 |
| Bull% | 31.0% |
| OVTLYR status | SELL (83d) |
| Sector rank | #529 |
| Next earnings | — |